Demisch L, Bochnik H J
Arzneimittelforschung. 1976;26(6):1149-51.
In 30% of the psychiatric patients investigated the lithium concentration in erythrocytes (RBC-lithium) is a more reliable indicator for the evaluation of the clinical response and the risk of toxicity. After lithium administration the lithium RBC levels increased within the first three weeks. Lithium RBC/plasma ratios are not different between unipolar, bipolar and schizo-affective psychoses. It was found that low lithium RBC/plasma ratios correspond with low monoamine oxidase (MAO) activity in platelets.
在接受调查的30%的精神科患者中,红细胞中的锂浓度(红细胞锂)是评估临床反应和毒性风险更可靠的指标。服用锂后,红细胞锂水平在前三周内升高。单相、双相和分裂情感性精神病患者的红细胞锂/血浆比率没有差异。研究发现,低红细胞锂/血浆比率与血小板中低单胺氧化酶(MAO)活性相关。